Tearing Down Barriers to Oncology Trials with eConsent

The oncology field is rapidly evolving, driven by groundbreaking advances in cancer research that have uncovered a growing number of treatment targets.

As a result, the race to develop innovative therapies is more intense than ever. To meet this demand, there is an increasing focus on technologies and systems that can enhance recruitment, improve patient retention, and ensure the collection of high-quality, compliant data.

In this article, learn how eConsent, when effectively implemented, stands out as a powerful tool in this effort. It addresses common barriers in clinical trials, streamlining processes and improving efficiency, ultimately supporting the development of new therapies.

This article originally appeared in Journal for Clinical Studies.